RCH Achieves AWS Life Sciences Competency
Leading Cloud solutions exclusively for Life Sciences teams that accelerate discovery, optimize costs and ensure scalability and compliance in AWS.
About the whitepaper:
AI coding assistants are changing how quickly software can move from an idea to implementation. But in Life Sciences, faster development only creates value when teams can still understand what was built, why decisions were made, and whether the resulting software remains aligned with clearly defined requirements.
As AI becomes more embedded in software delivery, teams need an approach that combines speed with structure. Spec-Driven Development provides a framework for doing that by making the specification, rather than a sequence of prompts, the foundation for design, implementation, and review.
This whitepaper, written by Diana Gamez, Head of Data & AI Engineering at MIGx, explores where unstructured AI-assisted coding can introduce risk, how clearer specifications improve delivery, and why human judgment remains essential as AI takes on a larger role in software engineering.
AI-assisted coding can accelerate early development, particularly when teams are experimenting or working on clearly bounded tasks. Gartner has projected that 75% of enterprise software engineers will use AI code assistants by 2028, reflecting how quickly these tools are entering mainstream development.
The challenge begins when conversational prompts become the primary record of intent. Architectural decisions, constraints, dependencies, and edge cases can remain implicit, making generated software harder to review, maintain, and govern.
Spec-Driven Development changes that relationship by putting an approved specification first. AI still accelerates execution, but it works within boundaries that people define and review.
That structured approach complements the same principles RCH brings to well-architected, scalable, and maintainable software solutions and to scientific platforms spanning R&D, Clinical, and analytics environments.
The whitepaper organizes the approach into four connected stages, each designed to create a clearer path from requirement to implementation:
The whitepaper also looks at how formats such as Given/When/Then can help teams define expected behavior more clearly and reduce interpretation during implementation. It also highlights why technical choices should follow defined requirements rather than simply being introduced because they appear plausible.
Even widely used libraries such as NumPy illustrate that broader point. The question is not whether a technology is useful, but whether it is appropriate for the specific requirement and context.
Life Sciences software often needs to support traceability, validation readiness, controlled change, and secure handling of information. That makes structure especially important as organizations explore moving GenAI from experimentation into practical applications.
The broader issue also extends beyond coding. As discussed in The Great AI Divide, organizations need to consider whether AI is strengthening human understanding or simply accelerating output while weakening the reasoning behind it.
RCH helps Life Sciences organizations bring greater structure and control to AI-assisted software delivery through expertise in Software Engineering, GenAI, scientific computing, Cloud, and Platform & Application Solutions. Working together with MIGx, we combine that technical depth with complementary strengths in knowledge management and semantics, GxP-aware infrastructure and compliance, and AI implementation, helping teams improve specification design, traceability, reviewability, and validation readiness across R&D, Clinical, and Bio-IT environments.
Book a strategic consultation to explore how your organization can apply Spec-Driven Development with greater clarity, control, and confidence.